Rating History for Gilead Sciences (GILD) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/23/2022 | Andrew Berens | New Coverage | Market Perform (N/A) |
68.00 (N/A) |
63.27 (65.27) |
3.16% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/23/2022 | Andrew Berens | New Coverage | Market Perform (N/A) |
68.00 (N/A) |
63.27 (65.27) |
3.16% | Details |
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
